Holdsworth E, Berim A, Gang D, Williams J, Smith C, Caffe B
Breastfeed Med. 2024; 19(7):515-524.
PMID: 38695182
PMC: 11695799.
DOI: 10.1089/bfm.2024.0021.
Igwe J, Alaribe U
J Cannabis Res. 2024; 6(1):18.
PMID: 38582889
PMC: 10998318.
DOI: 10.1186/s42238-024-00228-w.
English A, Uittenbogaard F, Torrens A, Sarroza D, Slaven A, Piomelli D
Elife. 2024; 12.
PMID: 38214701
PMC: 10945583.
DOI: 10.7554/eLife.89867.
Eichler F, Pozniak B, Machnik M, Schenk I, Wingender A, Baudisch N
Front Vet Sci. 2023; 10:1234551.
PMID: 37621871
PMC: 10445762.
DOI: 10.3389/fvets.2023.1234551.
Takeda S, Hirao-Suzuki M, Aramaki H, Watanabe K
Forensic Toxicol. 2022; 41(2):287-293.
PMID: 36583834
DOI: 10.1007/s11419-022-00655-5.
RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats.
Lovelock D, Nguyen T, Van Voorhies K, Zhang Y, Besheer J
J Pharmacol Exp Ther. 2021; 380(3):153-161.
PMID: 34930820
PMC: 11047052.
DOI: 10.1124/jpet.121.000919.
The effects of cannabis and cannabinoids on the endocrine system.
Meah F, Lundholm M, Emanuele N, Amjed H, Poku C, Agrawal L
Rev Endocr Metab Disord. 2021; 23(3):401-420.
PMID: 34460075
DOI: 10.1007/s11154-021-09682-w.
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control.
Ewell T, Abbotts K, Williams N, Butterklee H, Bomar M, Harms K
Pharmaceuticals (Basel). 2021; 14(8).
PMID: 34451914
PMC: 8398280.
DOI: 10.3390/ph14080817.
An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses.
Hinckley J, Saba L, Raymond K, Bartels K, Klawitter J, Christians U
Cannabis Cannabinoid Res. 2021; 7(1):65-77.
PMID: 33998853
PMC: 8864439.
DOI: 10.1089/can.2020.0002.
Comparison of Five Oral Cannabidiol Preparations in Adult Humans: Pharmacokinetics, Body Composition, and Heart Rate Variability.
Williams N, Ewell T, Abbotts K, Harms K, Woelfel K, Dooley G
Pharmaceuticals (Basel). 2021; 14(1).
PMID: 33418866
PMC: 7825058.
DOI: 10.3390/ph14010035.
Is adipose tissue suitable for detection of (synthetic) cannabinoids? A comparative study analyzing antemortem and postmortem specimens following pulmonary administration of JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol to pigs.
Schaefer N, Nordmeier F, Kroll A, Korbel C, Laschke M, Menger M
Arch Toxicol. 2020; 94(10):3421-3431.
PMID: 32666126
PMC: 7502066.
DOI: 10.1007/s00204-020-02843-x.
Comparative Pharmacokinetics of Δ-Tetrahydrocannabinol in Adolescent and Adult Male Mice.
Torrens A, Vozella V, Huff H, McNeil B, Ahmed F, Ghidini A
J Pharmacol Exp Ther. 2020; 374(1):151-160.
PMID: 32345621
PMC: 7318794.
DOI: 10.1124/jpet.120.265892.
Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
Fernandez-Trapero M, Perez-Diaz C, Espejo-Porras F, de Lago E, Fernandez-Ruiz J
Biomolecules. 2020; 10(2).
PMID: 32054131
PMC: 7072526.
DOI: 10.3390/biom10020279.
Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
Schuster R, Potter K, Vandrey R, Hareli M, Gilman J, Schoenfeld D
J Psychopharmacol. 2019; 34(2):197-210.
PMID: 31535597
PMC: 6989351.
DOI: 10.1177/0269881119872206.
Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.
Goncalves J, Rosado T, Soares S, Simao A, Caramelo D, Luis A
Medicines (Basel). 2019; 6(1).
PMID: 30813390
PMC: 6473697.
DOI: 10.3390/medicines6010031.
The pharmacokinetics and the pharmacodynamics of cannabinoids.
Lucas C, Galettis P, Schneider J
Br J Clin Pharmacol. 2018; 84(11):2477-2482.
PMID: 30001569
PMC: 6177698.
DOI: 10.1111/bcp.13710.
Self-reported marijuana use over 25 years and abdominal adiposity: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Bancks M, Auer R, Carr J, Goff Jr D, Kiefe C, Rana J
Addiction. 2017; 113(4):689-698.
PMID: 29127726
PMC: 5847434.
DOI: 10.1111/add.14097.
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.
Kevin R, Lefever T, Snyder R, Patel P, Fennell T, Wiley J
Forensic Toxicol. 2017; 35(2):333-347.
PMID: 28824730
PMC: 5519669.
DOI: 10.1007/s11419-017-0361-1.
Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.
Schaefer N, Kettner M, Laschke M, Schlote J, Ewald A, Menger M
Curr Neuropharmacol. 2016; 15(5):713-723.
PMID: 27834143
PMC: 5771047.
DOI: 10.2174/1570159X15666161111114214.
Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner E, Swortwood M, Hirvonen J, Goodwin R, Bosker W, Ramaekers J
Drug Test Anal. 2015; 8(7):682-9.
PMID: 26097154
PMC: 4676741.
DOI: 10.1002/dta.1825.